Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEWEL JOHL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1407852858
CMS profile
18863
Location
WALNUT CREEK, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$50,520.92

370 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
JAZZ PHARMACEUTICALS INC. $13,127.44 14
E.R. Squibb & Sons, L.L.C. $10,059.56 26
Genentech USA, Inc. $8,283.78 23
AstraZeneca Pharmaceuticals LP $6,016.01 31
Geron Corporation $2,610.42 9
Genmab U.S., Inc. $1,650.74 9
BeOne Medicines USA, Inc. $1,513.47 10
Incyte Corporation $999.88 7
Janssen Biotech, Inc. $556.09 21
Merck Sharp & Dohme LLC $438.59 16
Novartis Pharmaceuticals Corporation $379.08 12
PFIZER INC. $376.33 17
Celgene Corporation $332.63 13
ARRAY BIOPHARMA INC $221.31 8
Daiichi Sankyo Inc. $207.94 11
GENZYME CORPORATION $206.69 7
Gilead Sciences, Inc. $197.19 6
Takeda Pharmaceuticals U.S.A., Inc. $175.16 13
GlaxoSmithKline, LLC. $165.14 6
Eisai Inc. $149.83 6
Astellas Pharma US Inc $143.06 6
Karyopharm Therapeutics Inc. $134.65 6
Telix Pharmaceuticals $134.45 2
Alexion Pharmaceuticals, Inc. $126.66 4
PharmaEssentia USA Corporation $125.27 5
Exelixis Inc. $118.01 3
Stemline Therapeutics Inc. $117.51 3
Genentech, Inc. $117.19 1
SERVIER PHARMACEUTICALS LLC $109.07 4
Bayer Healthcare Pharmaceuticals Inc. $103.97 4
Syndax Pharmaceuticals, Inc. $95.31 4
SEAGEN INC. $92.99 1
SOBI, INC $87.21 3
Agios Pharmaceuticals, Inc. $84.50 4
ABBVIE INC. $81.44 4
Aveo Pharmaceuticals, Inc. $76.08 3
SpringWorks Therapeutics, Inc. $72.33 3
ADC THERAPEUTICS AMERICA, INC. $60.89 3
Pharmacosmos Therapeutics Inc. $53.56 2
PUMA BIOTECHNOLOGY, INC. $50.57 2
Coherus Oncology, Inc. $50.52 2
EMD Serono, Inc. $46.12 2
Invivyd Inc $44.08 2
Spectrum Pharmaceuticals Inc. $40.38 2
Sumitomo Pharma America, Inc. $40.23 2
Boehringer Ingelheim Pharmaceuticals, Inc. $36.13 2
Iovance Biotherapeutics, Inc. $34.95 1
BeiGene USA, Inc. $34.84 1
Ipsen Biopharmaceuticals, Inc $34.67 1
Novocure Inc. $32.86 2
Lilly USA, LLC $32.61 1
Deciphera Pharmaceuticals Inc. $32.14 1
Caris MPI, Inc. $28.37 1
KYOWA KIRIN, INC. $27.97 1
TAIHO ONCOLOGY, INC. $26.99 1
Regeneron Healthcare Solutions, Inc. $25.99 1
Kite Pharma, Inc. $25.44 1
TerSera Therapeutics LLC $24.39 1
Amgen Inc. $23.43 1
Immunocore Limited $23.41 1
Nuvation Bio Inc. $21.85 1
Fennec Pharmaceuticals, Inc. $21.79 1
Legend Biotech USA Inc. $21.27 1
PROGENICS PHARMACEUTICALS, INC. $20.04 1
Azurity Pharmaceuticals, Inc. $19.82 1
Rigel Pharmaceuticals, Inc. $19.47 1
RECORDATI_RARE_DISEASES_INC. $18.06 1
Janssen Pharmaceuticals, Inc $15.99 1
SUN PHARMACEUTICAL INDUSTRIES INC. $15.77 1
Napo Pharmaceuticals Inc $15.49 1
ACCORD HEALTHCARE, INC. $13.85 1

Page 5 of 8; records 201–250 of 370 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEWEL JOHL

NPI 1407852858 · CMS profile ID 18863

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WALNUT CREEK, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 8; records 201–250 of 370 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1407852858?year=2025&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEWEL JOHL, NPI 1407852858, CMS profile ID 18863. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 370 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1407852858?year=2025&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JEWEL JOHL, NPI 1407852858, CMS profile ID 18863. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 370 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1407852858?year=2025&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JEWEL JOHL, NPI 1407852858, CMS profile ID 18863, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 8; records 201–250 of 370 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1407852858?year=2025&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

370 matching records · $50,520.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 370 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 370.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ARRAY BIOPHARMA INC $29.7206/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230568072 CMS
PFIZER INC. $0.8706/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230626734 CMS
SEAGEN INC. $92.9906/23/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1230553903 CMS
Alexion Pharmaceuticals, Inc. $33.4806/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202954642 CMS
PUMA BIOTECHNOLOGY, INC. $26.0906/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251743266 CMS
AstraZeneca Pharmaceuticals LP $1,340.0006/19/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1206244394 CMS
Gilead Sciences, Inc. $21.2006/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234514506 CMS
AstraZeneca Pharmaceuticals LP $1,675.0006/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1206757304 CMS
BeOne Medicines USA, Inc. $13.5606/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202896816 CMS
E.R. Squibb & Sons, L.L.C. $26.2806/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590777 CMS
E.R. Squibb & Sons, L.L.C. $0.2006/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590783 CMS
JAZZ PHARMACEUTICALS INC. $38.8006/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234315051 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.1106/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223913202 CMS
E.R. Squibb & Sons, L.L.C. $355.0006/12/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1184590833 CMS
AstraZeneca Pharmaceuticals LP $25.2206/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206746272 CMS
Lilly USA, LLC $32.6106/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186742253 CMS
PROGENICS PHARMACEUTICALS, INC. $20.0406/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245243966 CMS
PFIZER INC. $32.5806/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230626118 CMS
Exelixis Inc. $32.1006/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218795739 CMS
Daiichi Sankyo Inc. $29.4806/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197101863 CMS
Incyte Corporation $23.7406/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226124961 CMS
E.R. Squibb & Sons, L.L.C. $355.0006/03/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1184590827 CMS
Janssen Biotech, Inc. $32.9406/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174872671 CMS
Deciphera Pharmaceuticals Inc. $32.1406/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235959688 CMS
E.R. Squibb & Sons, L.L.C. $1,420.0005/30/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1184590829 CMS
Genentech USA, Inc. $24.9005/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211524122 CMS
Genentech USA, Inc. $0.9605/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211524124 CMS
GlaxoSmithKline, LLC. $17.5005/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190431139 CMS
Spectrum Pharmaceuticals Inc. $21.2405/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1221049557 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1.2405/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223797318 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.1205/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223841668 CMS
PFIZER INC. $28.3205/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230549923 CMS
PFIZER INC. $1.0005/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230562418 CMS
AstraZeneca Pharmaceuticals LP $43.0805/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206871682 CMS
E.R. Squibb & Sons, L.L.C. $18.9605/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590759 CMS
E.R. Squibb & Sons, L.L.C. $0.2205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590761 CMS
E.R. Squibb & Sons, L.L.C. $0.9405/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590763 CMS
SOBI, INC $27.7405/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240250127 CMS
Stemline Therapeutics Inc. $55.6205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244095265 CMS
Janssen Biotech, Inc. $26.6605/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174874151 CMS
Janssen Biotech, Inc. $1.5705/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174870416 CMS
Merck Sharp & Dohme LLC $22.0905/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238365211 CMS
ARRAY BIOPHARMA INC $24.5505/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230549286 CMS
Gilead Sciences, Inc. $102.2205/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234401179 CMS
Merck Sharp & Dohme LLC $28.0305/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238220496 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.1905/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225592094 CMS
Genmab U.S., Inc. $18.5305/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235920688 CMS
PharmaEssentia USA Corporation $21.2105/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246825526 CMS
Celgene Corporation $25.6505/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184590769 CMS
Daiichi Sankyo Inc. $13.8005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197088221 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,581.31 84
PY2020 $17,156.97 49
PY2021 $42,384.10 69
PY2022 $33,892.60 81
PY2023 $75,994.91 154
PY2024 $55,207.83 161
PY2025 $50,520.92 370

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,117.91 2
PY2025 Principal investigator $113,738.16 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $10,725.00 10/10/2025 Non-covered Recipient Entity
BASS MEDICAL GROUP
A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF OLOMORASIB IN COMBINATION WITH STANDARD OF CARE IMMUNOTHERAPY IN PARTICIPANTS WITH RESECTED OR UNRESECTABLE KRAS G12C-MUTANT, NON-SMALL CELL LUNG CANCER - SUNRAY-02 No dispute reported 06/30/2026 1187875287
Principal investigator 1 Merck Sharp & Dohme LLC $101,272.36 08/31/2025 Non-covered Recipient Entity
Bass Medical Group
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Treatment of Physician s Choice TPC in Participants With Triple-Negative Breast Cancer TNBC Who Received No dispute reported 06/30/2026 1232923756
Recipient Eli Lilly and Company $478.00 07/28/2025 Covered Recipient Physician A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF OLOMORASIB IN COMBINATION WITH STANDARD OF CARE IMMUNOTHERAPY IN PARTICIPANTS WITH RESECTED OR UNRESECTABLE KRAS G12C-MUTANT, NON-SMALL CELL LUNG CANCER - SUNRAY-02 No dispute reported 06/30/2026 1187873713
Principal investigator 1 AstraZeneca UK Limited $1,740.80 05/08/2025 Non-covered Recipient Entity
GREGORY RHODES MD CANCER CENTER
An Observational Multi-center Study to Evaluate Real-World Treatment Outcomes of Durvalumab-based Regimens in Hepatobiliary Cancers No dispute reported 06/30/2026 1185546139
Recipient Eli Lilly and Company $639.91 02/25/2025 Covered Recipient Physician SUNRAY-01 A GLOBAL PIVOTAL STUDY IN PARTICIPANTS WITH KRAS G12C-MUTANT LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER COMPARING FIRST LINE TREATMENT OF LY3537982 AND PEMBROLIZUMAB VS PLACEBO AND PEMBROLIZUMAB IN THOSE WITH PD L1 EXPRESSION 50% OR LY3537982 AND PEMBROLIZUMAB PEMETREXED PLATINUM VS PLACEBO AND PEMBROLIZUMAB PEMETREXED PLATINUM REGARDLESS OF PD-L1 EXPRESSION No dispute reported 06/30/2026 1187873471